Stratview Research has published a new report titled “Anticancer Drug Market” which is segmented By Type (Targeted Drugs, Cytotoxic Drugs, Hormonal Drugs), Application (Immunotherapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Region.

As per the study, the Anticancer Drug Market is projected to grow from USD 152.07 billion in 2021 to USD 246.14 billion by 2028 at a CAGR of around 7.08% during the forecast period of 2022-2028.

Report Highlights

This report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can affect the market dynamics of the industry. It provides thorough analysis of the market segments which include products, applications, and competitor analysis.

The market is bifurcated into various segments. Below given is the segment-wise analysis -

By application, the anticancer drug market has been bifurcated into immunotherapy, targeted therapy, chemotherapy, hormonal therapy, and others. The chemotherapy segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period.

By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to rising healthcare expenditure, the presence of a large patient population, and early adoption of advanced drugs coupled with the presence of key market players such as Celgene Corporation (US) and Pfizer Inc. (US). The market growth in Asia-Pacific is expected to be driven by the rising number of cancer patients coupled with increasing investment in R&D activities to develop advanced cancer treatment solutions.

Who are the Key Players in the Market?

This report provides market intelligence in the most comprehensive way. It also provides critical insights into the key players active in the market, that will enable strategic decision-making for the existing market players as well as those willing to enter the market. The following are the key players activen in the Anticancer Drug Market:

  • Hoffmann-La Roche AG (Switzerland)
  • Celgene Corporation (US)
  • Pfizer Inc. (US)
  • Bristol Myers Squibb (US)
  • Novartis International AG (Switzerland)
  • AstraZeneca plc (UK)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Bayer AG (Germany)
  • GlaxoSmithKline plc (UK)

Request a sample here- https://www.stratviewresearch.com/Request-Sample/2417/Anticancer-Drug-Market.html#form

Custom Research:

Stratview research delivers custom research services across the sectors. In case of any custom research requirements, please send your inquiry to [email protected]. Or connect with our experts at +1-313-307-4176.

About Us

Stratview Research is a global market research firm, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with insightful market data to aid strategic decision making. These exclusive reports are the result of exclusive research methodology and are available for key industries such as chemicals, composites, advanced materials, technology, renewable energy, and more.